The Valley Desk

NCT05032820 · Interventional trial

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

Overall registry status Completed

Phase 2

Conditions Multiple Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov